Cetera Investment Advisers Moderna, Inc. Transaction History

Cetera Investment Advisers

$41.3 Billion
Q1 2024

A detailed history of Cetera Investment Advisers transactions in Moderna, Inc. stock. As of the latest transaction made, Cetera Investment Advisers holds 68,390 shares of MRNA stock, worth $8.28 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

68,390

Previous 3,664 1766.54%

Holding current value

$8.28 Million

Previous $390,000 1768.46%

% of portfolio

0.02%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 24, 2024	BUY	$85.37 - $115.44 $5.53 Million - $7.47 Million	64,726 Added 1766.54%	68,390 $7.29 Million
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $540,562 - $730,966	-6,332 Reduced 63.35%	3,664 $390,000
Q4 2023 Feb 13, 2024	SELL	$69.51 - $104.43 $142,704 - $214,394	-2,053 Reduced 17.04%	9,996 $994,000
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $16,775 - $22,030	174 Added 1.47%	12,049 $1.24 Million
Q2 2023 Aug 09, 2023	BUY	$118.5 - $160.53 $40,290 - $54,580	340 Added 2.95%	11,875 $1.44 Million

Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $51,415 - $74,670	-379 Reduced 3.18%	11,535 $1.77 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $822,385 - $1.46 Million	6,947 Added 139.86%	11,914 $2.14 Million
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $1.05 Million - $1.72 Million	-8,856 Reduced 64.07%	4,967 $587,000
Q2 2022 Aug 11, 2022	SELL	$117.13 - $176.59 $275,138 - $414,809	-2,349 Reduced 14.53%	13,823 $1.98 Million
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $95,097 - $176,757	-752 Reduced 4.44%	16,172 $2.79 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $29,130 - $47,537	-129 Reduced 0.76%	16,924 $4.3 Million
Q3 2021 Nov 16, 2021	BUY	$221.9 - $484.47 $768,661 - $1.68 Million	3,464 Added 25.49%	17,053 $6.56 Million
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $711,387 - $1.29 Million	-5,476 Reduced 28.72%	13,589 $3.19 Million
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $1.1 Million - $1.87 Million	-10,053 Reduced 34.53%	19,065 $2.5 Million
Q4 2020 Feb 17, 2021	BUY	$65.74 - $169.86 $1.91 Million - $4.95 Million	29,118 New	29,118 $3.04 Million
Q2 2020 Aug 13, 2020	SELL	$29.67 - $80.0 $522,963 - $1.41 Million	-17,626 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$17.78 - $31.58 $313,390 - $556,629	17,626 New	17,626 $528,000

Others Institutions Holding MRNA

# of Institutions

1,045

Shares Held

245M

Call Options Held

12.1M

Put Options Held

9.34M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $47.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Investment Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Investment Advisers with notifications on news.

Account

Cetera Investment Advisers Moderna, Inc. Transaction History